Ozmosis Research Inc.
22
4
7
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.5%
1 terminated/withdrawn out of 22 trials
88.9%
+2.4% vs industry average
5%
1 trials in Phase 3/4
13%
1 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
Role: collaborator
Inspiratory Muscle Training in Lung Transplant Candidates
Role: collaborator
Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
Role: collaborator
A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML)
Role: collaborator
Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Role: collaborator
ATG Plus PTCy vs ATG for CGVHD Prophylaxis
Role: collaborator
Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia
Role: collaborator
Study of Allogeneic Double Negative T Cells (DNT-UHN-1) in Patients With High Risk Acute Myeloid Leukemia
Role: collaborator
NEoadjuvant Olaparib Combination OvArian Cancer Targeted Study
Role: collaborator
SCION: SABR and Checkpoint Inhibition of NSCLC
Role: collaborator
Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection
Role: collaborator
Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT)
Role: collaborator
Autologous Stem Cell Transplantation of Cells Engineered to Express Alpha-Galactosidase A in Patients With Fabry Disease
Role: collaborator
Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC
Role: collaborator
Rosuvastatin in the Treatment of Rectal Cancer
Role: collaborator
A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients
Role: collaborator
A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer
Role: lead
Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
Role: collaborator
Treatment-free Remission Accomplished With Dasatinib in Patients With CML
Role: collaborator
PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.
Role: collaborator